A detailed history of Handelsinvest Investeringsforvaltning transactions in Eli Lilly & CO stock. As of the latest transaction made, Handelsinvest Investeringsforvaltning holds 3,721 shares of LLY stock, worth $2.86 Million. This represents 1.39% of its overall portfolio holdings.

Number of Shares
3,721
Previous 4,393 15.3%
Holding current value
$2.86 Million
Previous $2.56 Million 13.04%
% of portfolio
1.39%
Previous 1.05%

Shares

18 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

Apr 19, 2024

SELL
$592.2 - $792.28 $397,958 - $532,412
-672 Reduced 15.3%
3,721 $2.9 Million
Q4 2023

Jan 11, 2024

SELL
$525.19 - $619.13 $1.17 Million - $1.38 Million
-2,232 Reduced 33.69%
4,393 $2.56 Million
Q3 2023

Oct 26, 2023

SELL
$434.7 - $599.3 $468,606 - $646,045
-1,078 Reduced 13.99%
6,625 $3.56 Million
Q2 2023

Aug 07, 2023

BUY
$350.74 - $468.98 $283,748 - $379,404
809 Added 11.73%
7,703 $3.61 Million
Q1 2023

Apr 27, 2023

BUY
$310.63 - $364.82 $42,245 - $49,615
136 Added 2.01%
6,894 $2.37 Million
Q4 2022

Jan 18, 2023

SELL
$321.55 - $374.67 $580,719 - $676,654
-1,806 Reduced 21.09%
6,758 $2.47 Million
Q3 2022

Nov 07, 2022

SELL
$296.48 - $337.87 $296,480 - $337,870
-1,000 Reduced 10.46%
8,564 $2.77 Million
Q2 2022

Jul 13, 2022

SELL
$278.73 - $327.27 $1.33 Million - $1.56 Million
-4,776 Reduced 33.31%
9,564 $3.1 Million
Q1 2022

Apr 26, 2022

SELL
$234.69 - $291.66 $2.11 Million - $2.62 Million
-9,000 Reduced 38.56%
14,340 $4.11 Million
Q3 2021

Nov 02, 2021

BUY
$221.6 - $272.71 $221,600 - $272,710
1,000 Added 4.48%
23,340 $5.39 Million
Q1 2021

Apr 20, 2021

BUY
$164.32 - $212.72 $2.51 Million - $3.25 Million
15,291 Added 216.92%
22,340 $4.17 Million
Q4 2020

Jan 25, 2021

BUY
$130.46 - $172.63 $99,932 - $132,234
766 Added 12.19%
7,049 $1.19 Million
Q3 2020

Oct 26, 2020

BUY
$146.22 - $169.13 $146,220 - $169,130
1,000 Added 18.93%
6,283 $930,000
Q2 2020

Jul 17, 2020

SELL
$136.42 - $164.18 $81,851 - $98,508
-600 Reduced 10.2%
5,283 $867,000
Q1 2020

Apr 30, 2020

SELL
$119.05 - $147.35 $119,050 - $147,350
-1,000 Reduced 14.53%
5,883 $816,000
Q3 2019

Oct 22, 2019

BUY
$106.79 - $116.16 $149,506 - $162,624
1,400 Added 25.53%
6,883 $770,000
Q2 2019

Aug 08, 2019

BUY
$110.79 - $129.32 $256,257 - $299,117
2,313 Added 72.97%
5,483 $607,000
Q1 2019

Apr 11, 2019

BUY
$111.31 - $131.02 $352,852 - $415,333
3,170 New
3,170 $411,000

Others Institutions Holding LLY

About ELI LILLY & Co


  • Ticker LLY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 950,174,976
  • Market Cap $730B
  • Description
  • Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...
More about LLY
Track This Portfolio

Track Handelsinvest Investeringsforvaltning Portfolio

Follow Handelsinvest Investeringsforvaltning and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Handelsinvest Investeringsforvaltning, based on Form 13F filings with the SEC.

News

Stay updated on Handelsinvest Investeringsforvaltning with notifications on news.